Pharmaceutical Microbiology Highlights
are:
Friday, 25 November 2016
Friday, 11 November 2016
Global Congress
Pharma
Microbiology 2017 is scheduled with a vision of promoting the field of Pharmaceutical
Microbiology, is going to play its own role in the development of
applicability of Pharmaceuticals
as there will be an integration of outstanding and ingenious scientists with
enthusiastic graduates from all the related fields. Microbiology
is the branch of Science, Specifically biology dealing with the study of
Micro-organisms, or life too small to be seen with the naked eye.
Set to take place on 19st and 20th June 2017, the 4th annual
event in the sell-out Pharmaceutical
Microbiology series will bring together all levels of industry
professionals, providing essential insights into the latest advancements in
practice and technology, developments
in regulation and the global harmonisation of evolving microbiology methods.
Join us as we ask questions such as, what are the best
approaches in contamination control? Where does microbiological risk assessment
interact with HACCP?
How do we develop and manage the sterilisation and validation process? When can
we use a scoring system to avoid unnecessary microbiological testing? What are
the latest approaches to preventing biofilms?
Hear presentations from an array of market leaders such as
GSK, Genzyme, Abbott, Med Immune and AstraZeneca, address real world case
studies on the benefits and challenges of rapid methods, risk assessments and
objectionable organisms.
Pharma/BioTech companies face challenge on how to improve
quality of the safety data which is ever increasing in its quantity. Other
challenges include managing the dynamic regulatory requirements, etc. which
industries and the regulatory authorities face on a regular basis. In this
setup, we are looking at communication and networking as important tools that
can help industries and departments design new strategies to overcome the
several implications.
Top key
speakers include:
•
Olivier Chancel, Sterility and Aseptic Process
Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
•
Ruth Daniels, Head of MSAT, Microbiology,
Genzyme
•
Sara Gamberini, Molecular Biology Scientist,
Merck Serono
•
Hans Noordergraaf, Microbiologist, Abbott
Biologicals
•
Thomas Schwartz, Microbiology & Molecular
Biology Group Leader, Forschungszentrum Karlsrube Gmbh
•
Tim Eaton, Sterile Manufacturing, Specialist,
AstraZeneca
•
Stephen Rawling, Microbiology Team Leader,
GlaxoSmithKline
•
Phil Duncanson, Director of QC, MedImmune
Subscribe to:
Posts (Atom)